Controversy Surrounding Indonesia's Tobacco and E-Cigarette Regulation Draft

Sep.19.2024
Controversy Surrounding Indonesia's Tobacco and E-Cigarette Regulation Draft
Indonesia's Health Ministry is asked to suspend discussions on tobacco and e-cigarette safety regulations, sparking industry concerns.

According to a report from Metrotv News on September 18, the Indonesian Ministry of Health has been asked to suspend discussions on the draft of the 2024 Tobacco and E-cigarette Product Safety Regulation (RPMK). The regulation has been criticized for restricting the market space for tobacco and e-cigarette products, and potentially harming Indonesia's tobacco farming and tobacco industry chain.


According to reports, this suggestion was put forward during a national dialogue event held at the Ashley Hotel in Jakarta on September 17 by pesantren and the Community Development Center (P3M).


The event was attended by a total of 50 representatives from government agencies, farmers' associations, trade unions, retailers associations, businesses, tobacco industry associations, civil society alliances, academia, religious leaders, and media. P3M Director Sarmidi Husna expressed concerns about the RPMK 2024 draft primarily due to its proposed plain packaging regulations, which are seen as restrictive to the tobacco industry. Husna noted that there was insufficient public participation in the drafting process, making it unrepresentative.


Husna further explained that some provisions in the draft may cause harm to tobacco farmers, small and medium-sized enterprises, various associations, and the tobacco industry, triggering strong opposition from various parties.


Benguet Saragih, from the Disease Control Working Group at the Ministry of Health, clarified that RPMK 2024 is not aimed at getting people to quit smoking, but rather is intended to prevent children from smoking.


In response, the Chairman of the National Association of Islamic Scholars (PBNU), Miftah Faqih, emphasized that the process of formulating any laws must include a balanced participation from all parties and focus on the common good, otherwise these laws will be ineffective and unfair. The representative of the Ministry of Industry, Nugraha Prasetya Yogi, also stated that the Ministry of Industry was not included in the previous law-making process, which is very detrimental to trade and industry.


Union representative Sudarto pointed out that since the enactment of the 2003 Health Law and Government Regulation No. 28 of 2004, tobacco regulations have gradually been implemented, significantly impacting the tobacco leaf and tobacco products industry. Sudarto emphasized that industrial policies and tax policies have also been used to suppress legal tobacco consumption, leading to the frequent appearance of illegal tobacco products.


Gunawan from the Indonesian Commission for Social Justice and Human Rights (IHCS) is calling for the coordination of existing regulations and laws to protect the interests of tobacco farmers. Indonesian parliament member Muhammad Misbakhun mentioned that the influence of international giants has caused local economies and tobacco farmers to go bankrupt, and therefore calls for the government to be a facilitator in finding a solution to the problem.


Representatives from the Indonesian Tobacco Association, Budiman, believe that restricting the sale of tobacco products will have negative effects on production, employment, and raw material sourcing. Additionally, Kusnasi Mudi, the Secretary General of the National Tobacco Growers Association (APTI), also stated that the government needs to reexamine this regulation and communicate with the entire industry chain to prevent significant impact on the future development of the industry.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine's Cabinet of Ministers adopted Resolution No. 1259 on October 15, 2026, increasing excise stamp production fees for tobacco products and e-cigarette liquids by approximately 30.5%, from UAH 0.1643 to UAH 0.2144 per stamp. Fees for alcoholic beverages rose by about 30.2%. Separately, Ukraine's parliament passed Bill No. 15532 on October 13, proposing to postpone the full implementation of electronic excise stamps and traceability for alcohol, tobacco and e-cigarette liquids from November 1, 2026, to July 1, 2027. Parliament cited additional testing, configuration and integration requirements. The bill was sent to the president for signature on October 19.
Regulations
Oct.21
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives said on September 23 that it has joined the interagency Trade Fraud Task Force to strengthen enforcement against illegal, misdeclared and smuggled vape and tobacco products. ATF will bring its authority under the Prevent All Cigarette Trafficking Act into the task force, including registration, reporting, shipping and record-inspection requirements covering interstate sales of electronic nicotine delivery systems. ATF said the move will strengthen its ability to trace illicit products from U.S. points of entry through domestic trafficking and distribution networks.
News
Sep.28 by 2Firsts Perspectives
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
The U.S. FDA authorized 24 VELO nicotine pouch products from a British American Tobacco subsidiary, raising the total number of authorized products from 43 to 67, a 55.8% increase. The newly authorized 4 mg products include lime and passion fruit flavors and feature certified child-resistant packaging. VELO's first FDA marketing authorization adds BAT to a list previously limited to PMI and Altria products, while bringing the agency's nicotine pouch review pilot total to 47 authorized products.
Oct.30
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08